ProQR Therapeutics N.V. Banner Image

ProQR Therapeutics N.V.

  • Ticker PRQR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
ProQR Therapeutics N.V. Logo Image
  • 51-200 Employees
  • Based in Leiden, Netherlands
ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of genetic eye diseases such as Leber congenital amaurosis 10, Usher syndrome and autosomal dominant retinitis pigmentosa. Based on their unique proprietary RNA repair platform technologies they are growing their pipeline with patients and loved ones in mind.
4.8 / 5.0 (45)

ProQR Therapeutics N.V. reports have an aggregate usefulness score of 4.8 based on 45 reviews.

ProQR Therapeutics N.V.

Most Recent Annual Report

ProQR Therapeutics N.V.
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

ProQR Therapeutics N.V. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!